Mozobil
Brand for: Plerixafor
My Prescription
Payment
Select pharmacy
$116.00
$15.00 due at pharmacy
$116.00 - $15.00 = $101.00
$101.00 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$116.00
Print or send this coupon to your phone
AlbertsonsPowered byAbout Mozobil
Drug Details
Plerixafor, also known as Mozobil, is an injectable medication used to aid patients with non-Hodgkin's lymphoma or multiple myeloma in preparing for a stem cell transplant. It is used in conjunction with granulocyte-colony stimulating factor (G-CSF) to facilitate the movement of stem cells from the bone marrow into the bloodstream. This process allows for the collection of stem cells which are then reintroduced into the patient following chemotherapy or radiation treatment. Plerixafor works by blocking the CXCR4 protein on stem cells, preventing them from adhering to the bone marrow and thereby promoting their release into the bloodstream. This medication is typically administered by a healthcare professional in an outpatient setting.
Mozobil (Plerixafor) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1.2ML of 24MG/1.2ML | 1 Vial | $116.00 | $116.00 |
| 1.2ML of 24MG/1.2ML | 2 Vials | $224.00 | $112.00 |
| 1.2ML of 24MG/1.2ML | 3 Vials | $332.00 | $110.67 |
Mozobil FAQs
Mozobil is used to mobilize hematopoietic stem cells in patients with certain types of cancers, such as non-Hodgkin's lymphoma and multiple myeloma, to prepare them for collection and subsequent autologous stem cell transplantation.
Plerixafor is classified as a hematopoietic stem cell mobilizer.
Yes, plerixafor is FDA approved. It is used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.
Plerixafor can be hazardous if not used properly. It is a medication that should be administered under the supervision of a healthcare professional. Potential side effects include nausea, diarrhea, injection site reactions, and dizziness. It is important for patients to discuss their medical history and any other medications they are taking with their healthcare provider to ensure safe use.
Mozobil works by mobilizing hematopoietic stem cells from the bone marrow into the bloodstream. It is used in combination with a granulocyte-colony stimulating factor (G-CSF) to enhance the collection of stem cells for transplantation. Mozobil inhibits the CXCR4 chemokine receptor, which disrupts the interaction between stem cells and the bone marrow, allowing the cells to move into the peripheral blood where they can be collected more easily.